Dr. Oliyai provides executive and strategic leadership to over 1000 personnel responsible for global development and commercial manufacturing. His organization has three main functions: pharmaceutical development for small molecules, end-to-end development for biologics, and worldwide commercial manufacturing of all drug products. These functions include strategic sourcing to establish and maintain the global supply chain for all clinical and commercial programs.
Dr. Oliyai received a B.S. in Pharmacy from the Oregon State University and a Ph.D. in Pharmaceutical Chemistry from the University of Kansas. He is an inventor on multiple U.S. and international patents, and has contributed to the development and approval of over 25 new products. Dr. Oliyai has served as the Global Pharmaceutical Development and Manufacturing lead, coordinating API, Drug Product, Analytical, QC, and QA functions for programs such as Atripla®, Complera®, Stribild®, Sovaldi®, and Harvoni®.